mimedx

He replaces interim CEO Todd Newton, who was appointed in September 2022. Newton will remain in his role on the Board of Directors at the Marietta, Georgia–based advanced wound care and therapeutic biologics company.

Capper has nearly 30 years of medtech and life sciences experience. He most recently was CEO of BioTelemetry, which Royal Philips acquired for $2.8 billion. Before that, Capper was president and CEO of both Home Diagnostics and CCS Medical. He has held numerous leadership roles at Bayer as well.

“Over the past several months, the search committee has conducted an evaluation of very strong candidates for this role. Our focus has been to find an experienced executive with a track record of delivering results who shares in our enthusiasm for the future of this company,” Kathleen Beh…

He replaces interim CEO Todd Newton, who was appointed in September 2022. Newton will remain in his role on the Board of Directors at the Marietta, Georgia–based advanced wound care and therapeutic biologics company.

Capper has nearly 30 years of medtech and life sciences experience. He most recently was CEO of BioTelemetry, which Royal Philips acquired for $2.8 billion. Before that, Capper was president and CEO of both Home Diagnostics and CCS Medical. He has held numerous leadership roles at Bayer as well.

“Over the past several months, the search committee has conducted an evaluation of very strong candidates for this role. Our focus has been to find an experienced executive with a track record of delivering results who shares in our enthusiasm for the future of this company,” Kathleen Beh…

MiMedx (Nasdaq:MDXG) announced that it appointed Ricci S. Whitlow as its chief operating officer (COO).

Whitlow’s responsibilities include leading manufacturing, supply chain, procurement, quality and regulatory efforts. She joins from Catalent, where she most recently served as president of clinical supply services.

“We are happy to begin 2023 with the addition of Ricci Whitlow to the MiMedx leadership team,” said Todd Newton, MiMedx interim CEO. As our growth goals depend on our ability to manage these changes, we identified the need for a talented and capable operational leader with a unique span of scientific, technology, process and people-leadership expertise. We believe Ricci is this leader.”

Before her time at Catalent, Whitlow held leadership roles across a number of medtech companies. That list includes Optinose, Kinetic Concepts and Johnson & Johnson.

MiMedx, a regenerative medicine company, develops and distributes placental …

MiMedx (Nasdaq:MDXG) announced today that Timothy Wright will depart as CEO with board member K. Todd Newton set to serve in an interim role.

Wright served as MiMedx’s CEO since May 2019. Newton holds the interim position while the company’s board appointed a special committee to conduct a search for a new CEO.

The search committee includes chairperson M. Kathleen Behrens, as well as James Bierman and William A. Hawkins III. MiMedx will retain an executive search firm to support the process, too.

“On behalf of the entire MiMedx board of directors, I thank Tim for his contributions during an important time in MiMedx’s history and wish him all the best in his future endeavors,” Behrens said in a news release. “As we work to accelerate our performance, renew our focus on execution and capitalize on the significant opportunity within our wound care & surgical and regenerative medicine & biologics Innovatio…

MiMedx today announced it appointed Kate Surdez as chief human resources officer, effective immediately.

The newly created MiMedx chief human resources officer role will guide processes and programs that support sustainable growth. Surdez has more than 20 years of experience in human resources and has led talent acquisition, total rewards, succession and workforce planning, performance coaching and other organizational change management for multinational biotech companies.

“Kate is a seasoned executive with a passion for life sciences. She brings extensive experience in all elements of human resources and will be an influential part of advancing key business initiatives and talent strategies that align with our mission and objectives. I look forward to her contributions on our executive leadership team as we ensure MiMedx remains a long-term destination for top talent, and a thriving environment for our employees,” CEO Timothy Wright said in a news releas…